Funds holding SYNGEN BIOTECH CO LTD
ISIN TW0008279001 · Taiwan
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 1.4M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 357,700 | 1.1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Low-Priced Stock K6 Fund Fidelity Puritan Trust | 55,000 | 173.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 14,000 | 44.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 4,000 | 12.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Low-Priced Stock K6 Fund Fidelity Puritan Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | 0 | 430,700 | 0.0 % |
| 2026Q1 | 4 | 0 | 430,700 | 0.0 % |
| 2025Q4 | 4 | -1 | 430,700 | -1.1 % |
| 2025Q3 | 5 | 0 | 435,700 | 0.0 % |
| 2025Q2 | 5 | 0 | 435,700 | 0.0 % |
| 2025Q1 | 5 | 0 | 435,700 | +4.8 % |
| 2024Q4 | 5 | 0 | 415,700 | 0.0 % |
| 2024Q3 | 5 | 0 | 415,700 | 0.0 % |
| 2024Q2 | 5 | -1 | 415,700 | -0.5 % |
| 2024Q1 | 6 | -1 | 417,700 | -3.9 % |
| 2023Q4 | 7 | 434,700 |
Cite this page
Titelia. "Funds holding SYNGEN BIOTECH CO LTD". https://titelia.com/en/stocks/syngen-biotech-co-ltd-TW0008279001